Expression of CD64 on peripheral monocytes of RA patients correlates with disease severity (57), whereas treatment with anti-TNF agent infliximab and cytostatic drug methotrexate decreases expression of CD64, paralleled by a decrease in inflammatory markers (erythrocyte sedimentation rate and C-reactive protein) (58). The gene discussed is FCGR1A; the disease is rheumatoid arthritis.